Guide
Do not switch from an injection to a tablet without a prescriber. The medicines can differ by product, dose, indication and licence.
A tablet is not a direct substitute for every injection.
Rybelsus is the current UK GLP-1 tablet for type 2 diabetes.
UK weight-management GLP-1 treatment is still injection-led.
| Check | Why it matters |
|---|---|
| Current medicine | Ozempic, Wegovy, Mounjaro and Rybelsus are different products. |
| Reason for use | Diabetes and weight management are different prescribing questions. |
| Dose timing | Switching can need timing and monitoring. |
| Safety | Side effects and contraindications still matter. |
Not as a simple weight-loss tablet swap. Rybelsus is not licensed as a UK weight-loss medicine.
Ask a clinician. Route preference is only one factor.
Do not combine GLP-1 medicines unless a clinician specifically advises it.